MiR-543 promotes gastric cancer cell proliferation by targeting SIRT1

Biochemical and Biophysical Research Communications

Volumn 469, Issue 1, 2016, Pages 15-21

  Li, Juan ^a   Dong, Guoying ^a   Wang, Bo ^b   Gao, Wei ^c   Yang, Qing ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Gastric cancer; miR 543; Proliferation; SIRT1

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 543; SIRTUIN 1; UNCLASSIFIED DRUG; MIRN543 MICRORNA, HUMAN; PROTEIN BINDING; SIRT1 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; BIOINFORMATICS; CANCER CELL; CANCER GRADING; CANCER SIZE; CANCER STAGING; CELL CYCLE PROGRESSION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; STOMACH CANCER; STOMACH EPITHELIUM; UPREGULATION; CELL SIZE; GENETICS; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; CELL SIZE; HUMANS; LYMPHATIC METASTASIS; MICRORNAS; NEOPLASM GRADING; PROTEIN BINDING; SIRTUIN 1; STOMACH NEOPLASMS;

EID: 84951566980     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.11.062     Document Type: Article

References (29)

1. J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, D.M. Parkin, D. Forman, and F. Bray Cancer incidence and mortality worldwide sources, methods and major patients in GLOBOCAN 2012 Int. J. Cancer 136 2015 E359 E386
2. L.A. Torre, F. Bray, R.L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal Global cancer statistics, 2012 CA Cancer J. Clin 65 2015 87 108
3. S. Mocellin, D. Verdi, K.A. Pooley, and D. Nitti Genetic variation and gastric cancer risk: a field synopsis and meta-analysis Gut 64 2015 1209 1219
4. R. Wadhwa, S. Song, J.S. Lee, Y. Yao, Q. Wei, and J.A. Ajani Gastric cancer-molecular and clinical dimensions Nat. Rev. Clin. Onclo 10 2013 643 655
5. I. Riquelme, K. Saavedra, J.A. Espinoza, H. Weber, P. García, B. Nervi, M. Garrido, A.H. Corvalán, J.C. Roa, and C. Bizama Molecular classification of gastric cancer: towards a pathway-driven targeted therapy Oncotarget 6 2015 24750 24779
6. S. Imai, C.M. Armstrong, M. Kaeberlein, and L. Guarente Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase Nature 403 2000 795 800
7. R.A. Frye Phylogenetic classification of prokaryotic and eukaryotic Sir2-like protein Biochem. Biophys. Res. Commun 273 2000 793 798
8. H. Vaziri, S.K. Dessain, E. Ng Eaton, S.I. Imai, R.A. Frye, T.K. Pandita, L. Guarente, and R.A. Weinberg Hsir2 (SIRT1) functions as an NAD-dependent p53 deacetylase Cell 107 2001 149 159
9. C. Diaz-Ruiz, A.I. Rodriguez-Perez, D. Beiroa, J. Rodriguez-Pallares, and J.L. Labandeira-Garcia Reciprocal regulation between sirtuin-1 and angiotensin-II in the substantia nigra: implications for aging and neurodegeneration Oncotarget 6 2015 26675 26689
10. T. Sun, X. Li, P. Zhang, W.D. Chen, H.L. Zhang, D.D. Li, R. Deng, X.J. Qian, L. Jiao, J. Ji, Y.T. Li, R.Y. Wu, Y. Yu, G.K. Feng, and X.F. Zhu Acetylation of Beclin1 inhibits autophagosome maturation and promotes tumour growth Nat. Commun 6 2015 7215
11. S.M. Nadtochiy, W. Urciuoli, J. Zhang, X. Schafer, J. Munger, and P.S. Brookes Metabolomic profiling of the heart during acute ischemic preconditioning reveals a role for SIRT1 in rapid cardioprotective metabolic adaptation J. Mol. Cell Cardiol 88 2015 64 72
12. H.W. Lim, S.G. Kang, J.K. Ryu, B. Schilling, M. Fei, I.S. Lee, A. Kehasse, K. Shirakawa, M. Yokoyama, M. schnölzer, H.G. Kasler, H.S. Kwon, B.W. Gibson, H. Sato, K. Akassoglou, C. Xiao, D.R. Littman, M. Ott, and E. Verdin SIRT1 deacetylates RORγt and enhances Th17 cell generation J. Exp. Med 212 2015 607 617
13. A. Hu, J.J. Huang, R.L. Li, Z.Y. Lu, J.L. Duan, W.H. Xu, X.P. Chen, and J.P. Fan Curcumin as therapeutics for the treatment of head and neck squamous cell carcinoma by activating SIRT1 Sci. Rep 5 2015 13429
14. I.C. Chen, W.F. Chiang, H.H. Huang, P.F. Chen, Y.Y. Shen, and H.C. Chiang Role of SIRT1 in regulation of epithelial-to-mensenchymal transition in oral squamous cell carcinoma metastasis Mol. Cancer 13 2014 254
15. Q. Yang, B. Wang, W. Gao, S.Y. Huang, Z.F. Liu, W.J. Li, and J.H. Jia Mol. Cancer Res. 11 2013 1497 1507
16. A.K. Leung The whereabouts of microRNA actions: cytoplasm and beyond Trends Cell Biol. 25 2015 601 610
17. Z. Su, Z. Yang, Y. Xu, Y. Chen, and Q. Yu MicroRNAs in apoptosis, autophagy and necroptosis Oncotarget 6 2015 8474 8490
18. R.I. Gregory, and S. Lin MicroRNA biogenesis pathways in cancer Nat. Rev. Cancer 15 2015 321 333
19. X. Zhou, W. Zhu, H. Li, W. Wen, W. Cheng, F. Wang, Y. Wu, L. Qi, Y. Fan, Y. Chen, Y. Ding, J. Xu, J. Qian, Z. Huang, T. Wang, D. Zhu, Y. Shu, and P. Liu Diagnostic value of a plasma microRNA signature in gastric cancer: a microRNA expression analysis Sci. Rep 5 2015 11251
20. H. Shi, J. Han, S. Yue, T. Zhang, W. Zhu, and D. Zhang Prognostic significance of combined microRNA-206 and cyclinD2 in gastric cancer patients after curative surgery: a retrospective cohort study Biomed. Pharmacother 71 2015 210 215
21. X. Zhao, W. Dou, L. He, S. Liang, J. Tie, C. Liu, T. Li, Y. Lu, P. Mo, Y. Shi, K. Wu, Y. Nie, and D. Fan MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor Oncogene 32 2013 1363 1372
22. K.Y. Jang, S.J. Noh, N. Lehwald, G.Z. Tao, D.I. Bellovin, H.S. Park, W.S. Moon, D.W. Felsher, and K.G. Sylvester SIRT1 and c-Myc promote liver tumor cell survival and predict poor survival of human hepatocellular carcinomas PLoS One 7 2012 e45119
23. F. Zhang, J. Cui, X. Liu, B. Lv, X. Liu, Z. Xie, and B. Yu Roles of micrnRNA-34a targeting SIRT1 in mesenchymal stem cells Stem Cell Res. Ther 6 2015 195
24. J. Xu, L. Li, H.F. Yun, and Y.S. Han MiR-138 promotes smooth muscle cells proliferation and migration in db/db mice through downregulation of SIRT1 Biochem. Biophys. Res. Commun 463 2015 1159 1164
25. S. Deng, S. Zhu, B. Wang, X. Li, Y. Liu, Q. Qin, Q. Gong, Y. Niu, C. Xiang, J. Chen, J. Yan, S. Deng, T. Yin, M. Yang, H. Wu, C. Wang, and G. Zhao Chronic pancreatitis and pancreatic cancer demonstrate active epithelial-mesenchymal transition profile, regulatory by miR-217-SIRT1 pathway Cancer Lett. 355 2014 184 191
26. C.L. Haga, and D.G. Phinney MicorRNAs in the imprinted DLK1-DIO3 region repress the epithelial-to-mesenchymal transition by targeting the TWIST1 protein signaling network J. Biol. Chem. 287 2012 42695 42707
27. L. Bing, C. Hong, S. Li-Xin, and G. Wei MicroRNA-543 suppresses endometrial cancer oncogenicity via targeting FAK and TWIST1 expression Arch. Gynecol. Obstet 290 2014 533 541
28. N. Song, H. Liu, X. Ma, and S. Zhang Placental growth factor promotes metastases of ovarian cancer through miR-543-regulated MMP7 Cell Physiol Biochem 37 2015 1104 1112
29. L. Yu, L. Zhou, Y. Cheng, L. Sun, J. Fan, J. Liang, M. Guo, N. Liu, and L. Zhu MicroRNA-543 acts as an oncogene by targeting PAQR3 in hepatocellular carcinoma Am. J. Cancer Res 4 2014 897 906